Get started
Author

Yanjing Tang

Observed names: Tang, Yan-Jing, Tang, Yanjing, Yan-Jing Tang, Yan-jing Tang, YanJing Tang, Yan‐Jing Tang
Observed institutions: Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, XinHua Hospital, Shanghai Children's Medical Center, Chinese Academy of Meteorological Sciences, Guizhou Provincial Meteorological Bureau, Institute of Medicinal Plant Development
ORCID: 0000-0001-6790-7449
Observed ORCID: 0000-0001-6790-7449
OpenAlex ID: A5042198150
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial
2022 · Tianyi Wang, Yanjing Tang, et al. · Journal of Clinical Oncology · 104
PDF
Estimation of maize yield by using a process-based model and remote sensing data in the Northeast China Plain
2015 · Fengmei Yao, Yanjing Tang, et al. · Physics and Chemistry of the Earth Parts A/B/C · 87
The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia
2018 · Jie Zhao, Jian-Wei Liang, et al. · Leukemia · 69
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification
2022 · Ting Liu, Jianan Rao, et al. · Nature Communications · 39
PDF
Genome-wide analysis and prediction of genes involved in the biosynthesis of polysaccharides and bioactive secondary metabolites in high-temperature-tolerant wild Flammulina filiformis
2020 · Juan Chen, Jia-Mei Li, et al. · BMC Genomics · 31
Symbiotic and Asymbiotic Germination of Dendrobium officinale (Orchidaceae) Respond Differently to Exogenous Gibberellins
2020 · Juan Chen, Bo Yan, et al. · International Journal of Molecular Sciences · 31
PDF
Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG‐ALL‐2015
2020 · Yiping Zhu, Rong Yang, et al. · Cancer Medicine · 30
PDF
Comparative Transcriptomics Analysis of the Symbiotic Germination of D. officinale (Orchidaceae) With Emphasis on Plant Cell Wall Modification and Cell Wall-Degrading Enzymes
2022 · Juan Chen, Yanjing Tang, et al. · Frontiers in Plant Science · 27
Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy
2024 · Meng Su, Luoquan Chen, et al. · Frontiers in Immunology · 25
PDF
Long‐term results of the risk‐stratified treatment of childhood acute lymphoblastic leukemia in China
2018 · Shuhong Shen, Jiaoyang Cai, et al. · Hematological Oncology · 24
Minimal Residual Disease is a Prognostic Marker for Neuroblastoma With Bone Marrow Infiltration
2011 · Jiao-Yang Cai, Ci Pan, et al. · American Journal of Clinical Oncology · 24
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
2024 · Shunsuke Kimura, Chun Shik Park, et al. · Cancer Discovery · 19
Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia
2019 · Xiaoxiao Chen, Yanjing Tang, et al. · Frontiers of Medicine · 19
Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemia
2022 · Wenting Hu, Yin Ting Cheung, et al. · Cancer Medicine · 18
PDF
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse
2021 · Xinyu Wan, Xiaomin Yang, et al. · Cancer Research and Treatment · 17
PDF
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
2023 · Wenjie Li, Lixia Ding, et al. · Journal of Translational Medicine · 16
PDF
Successful Treatment of TCF3-HLF–positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy
2021 · Tianyi Wang, Xinyu Wan, et al. · Clinical Lymphoma Myeloma & Leukemia · 16
Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma
2007 · Jiao‐Yang Cai, Yan‐Jing Tang, et al. · Pediatric Blood & Cancer · 13
Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China
2017 · Jiaoyang Cai, Ci Pan, et al. · Journal of Cancer Research and Clinical Oncology · 12
Bicistronic-CD19/22 Chimeric Antigen Receptor T-Cell Therapy for Childhood Refractory Lupus Nephritis
2025 · Youying Mao, Weidong Shen, et al. · Kidney International Reports · 10
PDF
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
2023 · Han Wang, Huiying Sun, et al. · Nature Communications · 10
PDF
The Clinical Characteristics of ARDS in Children With Hematological Neoplasms
2021 · Qiao Zhang, Wen-ting Hu, et al. · Frontiers in Pediatrics · 8
PDF
The efficacy and safety of a homoharringtonine-based protocol for children with acute myeloid leukemia: A retrospective study in China
2020 · Yanjing Tang, Chengjuan Luo, et al. · Pediatric Hematology and Oncology · 8
NUDT15 Genetic Variants in Chinese Han, Uighur, Kirghiz, and Dai Nationalities
2022 · Fang Zhang, Gulbanur Amat, et al. · Frontiers in Pediatrics · 7
PDF
Safety and Efficacy of Bicistronic CD19/CD22 CAR T Cell Therapy in Childhood B Cell Acute Lymphoblastic Leukemia
2024 · Xinyu Wan, Wenjie Li, et al. · Blood · 6
Works count: 143
Citation count: 721
H-index: 16
I10-index: 21
Year
Topic
Type